AnyLearn Backgroung
Gadolinium-based contrast agents (GBCAs) are widely used in MRI to enhance image clarity, but they carry potential risks, particularly for patients with impaired kidney function, due to their association with nephrogenic systemic fibrosis (NSF). Recent advancements and guidelines emphasize the importance of using the lowest effective dose and choosing macrocyclic GBCAs to mitigate these risks while still achieving diagnostic efficacy.
History Empty State Icon

Your Lessons

Your lessons will appear here when you're logged in.

All content generated by artificial intelligence. Do not rely on as advice of any kind. Accuracy not guaranteed.

Privacy policy | Terms of Use

Copyright © 2024 AnyLearn.ai All rights reserved

Feedback?